Mesenchymal stromal cells; role in tissue repair, drug discovery and immune modulation

Current Drug Delivery

Volumn 11, Issue 5, 2014, Pages 561-571

  English, Karen ^a   Mahon, Bernard P ^a   Wood, Kathryn J ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Drug discovery; Mesenchymal stem cells; Mesenchymal stromal cells; Tissue repair; Transplantation tolerance

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL TRANSDIFFERENTIATION; CELL TRANSPLANTATION; DENDRITIC CELL; DRUG DEVELOPMENT; GRAFT REJECTION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; MESENCHYMAL STROMA CELL; NONHUMAN; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR; CYTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; WOUND HEALING;

CELL DIFFERENTIATION; DRUG DISCOVERY; HUMANS; IMMUNE TOLERANCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; WOUND HEALING;

EID: 84911494643     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201810999131125222440     Document Type: Article

References (167)

1. Young, H. E. Existence of reserve quiescent stem cells in adults, from amphibians to humans. Curr. Top Microbiol. Immunol., 2004, 280, 71-109.
2. Young, H. E., Duplaa, C., Romero-Ramos, M., Chesselet, M. F., Vourc'h, P., Yost, M. J., Ericson, K., Terracio, L., Asahara, T., Masuda, H., Tamura-Ninomiya, S., Detmer, K., Bray, R. A., Steele, T. A., Hixson, D., el-Kalay, M., Tobin, B. W., Russ, R. D., Horst, M. N., Floyd, J. A., Henson, N. L., Hawkins, K. C., Groom, J., Parikh, A., Blake, L., Bland, L. J., Thompson, A. J., Kirincich, A., Moreau, C., Hudson, J., Bowyer, F. P., 3rd, Lin, T. J., Black, A. C., Jr. Adult reserve stem cells and their potential for tissue engineering. Cell Biochem. Biophys., 2004, 40(1), 1-80.
3. Bearzi, C., Leri, A., Lo Monaco, F., Rota, M., Gonzalez, A., Hosoda T., Pepe, M., Qanud, K., Ojaimi, C., Bardelli, S, D'Amario D, D'Alessandro, D. A., Michler, R. E., Dimmeler, S., Zeiher, A. M., Urbanek, K., Hintze, T. H., Kajstura, J., Anversa, P. Identification of a coronary vascular progenitor cell in the human heart. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(37), 15885-15890.
4. Li, C., Yang, F., Sheppard, A. Adult stem cells and mammalian epimorphic regeneration-insights from studying annual renewal of deer antlers. Curr. Stem Cell Res. Ther., 2009, 4(3), 237-251.
5. Barry, F. P., Murphy, J. M. Mesenchymal stem cells, clinical applications and biological characterization. Int. J. Biochem. Cell Biol., 2004, 36(4), 568-584.
6. Horwitz, E. M. Stem cell plasticity, the growing potential of cellular therapy. Arch. Med. Res., 2003, 34(6), 600-606.
7. Caplan, A. I. Mesenchymal stem cells. J. Orthop. Res., 1991, 9(5), 641-650.
8. Caplan, A. I. The mesengenic process. Clin. Plast Surg. 1994, 21(3), 429-435.
9. Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., Keiliss-Borok, I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation, 1974, 17(4), 331-340.
10. Friedenstein, A. J. P., Petrokova, K. V. Osteogenesis in transplants of bone marrow cells. J. Embyol. Exp. Morphol., 1966, 16, 381-390.
11. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A, Low, W. C., Largaespada, D. A., Verfaillie, C. M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418(6893), 41-49.
12. Reyes, M., Verfaillie, C. M. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. N. Y. Acad. Sci., 2001, 938, 231-233.
13. D'Ippolito, G., Diabira, S., Howard, G. A., Menei, P., Roos, B. A., Schiller, P. C. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci., 2004, 117(Pt 14), 2971-2981.
14. D'Ippolito, G., Howard, G. A., Roos, B. A., Schiller, P. C. Sustained stromal stem cell self-renewal and osteoblastic differentiation during aging. Rejuvenation Res., 2006, 9(1), 10-19.
15. Seandel, M., James, D., Shmelkov, S. V., Falciatori, I., Kim, J., Chavala, S., Scherr, D. S., Zhang, F., Torres, R., Gale, N. W., Yancopoulos, G. D., Murphy, A., Valenzuela, D. M., Hobbs, R. M., Pandolfi PP, Rafii S. Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. Nature, 2007, 449(7160), 346-350.
16. Crisan, M., Yap, S., Casteilla, L., Chen, C. W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P. N., Traas, J., Schugar, R., Deasy, B. M., Badylak, S., Buhring, H. J., Giacobino, J. P., Lazzari, L., Huard, J., Peault, B. A. perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 2008, 3(3), 301-313.
17. Gonzalez, M. A, Gonzalez-Rey, E., Rico, L., Buscher, D., Delgado, M. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology, 2009, 136(3), 978-989.
18. Wang, H. S., Hung, S. C., Peng, S. T., Huang, C. C., Wei, H. M., Guo, Y. J., Fu, Y. S., Lai, M. C., Chen, C. C. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 2004, 22(7), 1330-1337.
19. Young, H. E., Mancini, M. L., Wright, R. P., Smith, J. C., Black, A. C., Jr., Reagan, C. R., Lucas, P. A. Mesenchymal stem cells reside within the connective tissues of many organs. Dev. Dyn., 1995, 202(2), 137-144.
20. Dominici, M, Le Blanc, K., Mueller, I., Slaper-Cortenbach, I, Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006, 8(4), 315-317.
21. Horwitz, E. M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Deans, R. J., Krause, D. S., Keating, A. Clarification of the nomenclature for MSC, The International Society for Cellular Therapy position statement. Cytotherapy. 2005, 7(5), 393-395.
22. Digirolamo, C. M., Stokes, D., Colter, D., Phinney, D. G., Class, R., Prockop, D. J. Propagation and senescence of human marrow stromal cells in culture, a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br. J. Haematol., 1999, 707(2), 275-281.
23. Muraglia, A., Cancedda, R., Quarto, R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J. Cell Sci., 2000, 113 (Pt 7), 1161-1166.
24. Haniffa, M. A., Collin, M. P., Buckley, C. D., Dazzi, F. Mesenchymal stem cells, fte fibroblasts' new cloftes? Haematologica, 2009, 94(2), 258-263.
25. Koga, H., Muneta, T., Nagase, T., Nimura, A., Ju, Y. J., Mochizuki, T., Sekiya, I. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis, suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res., 2008, 333(2), 207-215.
26. Huang, G. T., Gronthos, S., Shi, S. Mesenchymal stem cells derived from dental tissues vs. those from other sources, their biology and role in regenerative medicine. J. Dent. Res., 2009, 88(9), 792-806.
27. Chang, C., Niu, D., Zhou, H., Li, F., Gong, F. Mesenchymal stem cells contribute to insulin-producing cells upon microenvironmental manipulation in vitro. TransplantProc., 2007, 39(10), 3363-3368.
28. Chien, C. C., Yen, B. L., Lee, F. K, Lai, T. H., Chen, Y. C., Chan, S. H., Huang, H. I. In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells, 2006, 24(7), 1759-1768.
29. Fukunaga, A., Uchida, K., Hara, K., Kuroshima, Y., Kawase, T. Differentiation and angiogenesis of central nervous system stem cells implanted with mesenchyme into ischemic rat brain. Cell Transplant., 1999, 8(4), 435-441.
30. Herzog, E. L., Chai, L., Krause, D. S. Plasticity of marrow-derived stem cells. Blood, 2003, 102(10), 3483-3493.
31. Li, Y., Zhang, R., Qiao, H., Zhang, H., Wang, Y., Yuan, H., Liu, Q., Liu, D., Chen, L, Pei, X. Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J. Cell Physiol, 2007, 211(1), 36-44.
32. Munoz-Elias, G., Woodbury, D., Black, I. B. Marrow stromal cells, mitosis, and neuronal differentiation, stem cell and precursor functions. Stem Cells, 2003, 21(4), 437-448.
33. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science, 1999, 284(5411), 143-147.
34. Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J. Immunol., 2008, 180(4), 2581-2587.
35. Woodbury, D., Reynolds, K., Black, I. B. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J. Neurosci. Res., 2002, 69(6), 908-917.
36. Barry, F. P. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today, 2003, 69(3), 250-256.
37. Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, KK, Goodell, M. A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest., 2001, 107(11), 1395-1402.
38. Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., Anversa, P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann. N. Y. Acad. Sci., 2001, 938, 221-229, discussion 229-230.
39. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R, Nadal-Ginard, B., Bodine, D. M., Leri, A, Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature, 2001, 410(6829), 701-705.
40. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I, Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(18), 10344-10349.
41. Gojo, S., Gojo, N., Takeda, Y., Mori, T., Abe, H., Kyo, S., Hata, J., Umezawa A. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp. Cell Res., 2003, 288(1), 51-59.
42. Yamada, Y., Sakurada, K., Takeda, Y., Gojo, S., Umezawa, A. Single-cell-derived mesenchymal stem cells overexpressing Csx/Nkx2. 5 and GATA4 undergo the stochastic cardiomyogenic fate and behave like transient amplifying cells. Exp. Cell Res., 2007, 313(4), 698-706.
43. Shake, J. G., Gruber, P. J., Baumgartner, W. A., Senechal, G., Meyers, J., Redmond, J. M., Pittenger, M. F., Martin. B. J. Mesenchymal stem cell implantation in a swine myocardial infarct model, engraftment and functional effects. Ann. Thorac. Surg., 2002, 73(6), 1919-1925, discussion 1926.
44. Aurich, I., Mueller, L. P., Aurich, H., Luetzkendorf, J., Tisljar, K., Dollinger, M. M., Schormann, W., Walldorf, J., Hengstler, J. G., Fleig, W. E., Christ, B. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut, 2007, 56(3), 405-415.
45. di Bonzo, L. V., Ferrero, I., Cravanzola, C., Mareschi, K., Rustichell, D., Novo, E., Sanavio, F, Cannito, S., Zamara E, Bertero, M., Davit, A., Francica, S., Novelli, F., Colombatto, S., Fagioli, F., Parola, M. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine, engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, 2008, 57(2), 223-231.
46. Gupta, N., Su, X., Popov, B., Lee, J. W., Serikov, V., Matthay, M. A. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol., 2007, 179(3), 1855-1863.
47. Andrades, J. A., Han, B., Nimni, M. E., Ertl, D. C., Simpkins, R. J., Arrabal, M. P., Becerra, J. A modified rhTGF-beta1 and rhBMP-2 are effective in initiating a chondro-osseous differentiation pathway in bone marrow cells cultured in vitro. Connect Tissue Res., 2003, 44(3-4), 188-197.
48. Kasten, P., Vogel, J., Luginbuhl, R., Niemeyer, P., Tonak, M., Lorenz, H., Helbig, L., Weiss, S., Fellenberg, J., Leo, A., Simank, H. G., Richter, W. Ectopic bone formation associated with mesenchymal stem cells in a resorbable calcium deficient hydroxyapatite carrier. Biomaterials, 2005, 26(29), 5879-5889.
49. Ko, E. K., Jeong, S. I., Rim, N. G., Lee, Y. M., Shin, H., Lee, B. K. In vitro osteogenic differentiation of human mesenchymal stem cells and in vivo bone formation in composite nanofiber meshes. Tissue Eng. Part A., 2008, 14(12), 2105-2119.
50. Morigi, M., Benigni, A., Remuzzi, G., Imberti, B. The regenerative potential of stem cells in acute renal failure. Cell Transplant., 2006, 15 Suppl 1, S111-117.
51. Morigi, M., Imberti, B., Zoja, C., Corna, D., Tomasoni, S., Abbate, M., Rottoli, D, Angioletti S, Benigni A, Perico N, Alison M, Remuzzi, G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol., 2004, 15(7), 1794-1804.
52. Kode, J. A., Mukherjee, S., Joglekar, M. V., Hardikar, A. A. Mesenchymal stem cells, immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy, 2009, 11(4), 377-391.
53. Lange, C., Togel, F., Ittrich, H., Clayton, F., Nolte-Ernsting, C, Zander A. R., Westenfelder, C. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int., 2005, 68(4), 1613-1617.
54. Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., Westenfelder, C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol Renal Physiol, 2005, 289(1), F31-42.
55. Togel, F., Weiss, K., Yang, Y., Hu, Z., Zhang, P, Westenfelder, C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol., 2007, 292(5), F1626-1635.
56. Togel, F., Westenfelder, C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev. Dyn., 2007, 236(12), 3321-3331.
57. Togel, F., Yang, Y., Zhang, P., Hu, Z, Westenfelder, C. Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury. Am. J. Physiol. Renal Physiol., 2008, 295(1), F315-321.
58. Caplan, A. I. Why are MSCs therapeutic? New data, new insight. J. Pathol., 2009, 217(2), 318-324.
59. Caplan, A. I., Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell Biochem., 2006, 98(5), 1076-1084.
60. Dore-Duffy P. Pericytes, pluripotent cells of the blood brain barrier. Curr. Pharm. Des., 2008, 14(16), 1581-1593.
61. Bianco, P., Robey, P. G., Saggio, I., Riminucci, M. "Mesenchymal" stem cells in human bone marrow (skeletal stem cells), a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum. Gene Ther., 2010, 21(9), 1057-1066.
62. Charbord, P., Livne, E., Gross, G., Haupl, T., Neves, N. M., Marie, P., Bianco, P, Jorgensen, C. Human Bone Marrow Mesenchymal Stem Cells, A Systematic Reappraisal Via the Genostem Experience. Stem Cell Rev., 2011, 7(1), 34-42.
63. Lee, M. W., Choi, J., Yang, M. S., Moon, Y. J., Park, J. S., Kim, H. C., Kim, Y. J. Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem. Biophys. Res. Commun., 2004, 320(1), 273-278.
64. English, K., Barry, F. P., Field-Corbett, C. P., Mahon, B. P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol. Lett., 2007, 110(2), 91-100.
65. Opitz, C. A., Litzenburger, U. M., Lutz, C., Lanz, T. V., Tritschler, I., Koppel, A., Tolosa, E., Hoberg, M., Anderl, J., Aicher W. K., Weller, M, Wick, W., Platten, M. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells. 2009, 27(4), 909-919.
66. Polchert, D., Sobinsky, J., Douglas, G., Kidd, M., Moadsiri, A., Reina E, Genrich, K., Mehrotra, S, Setty, S., Smith, B., Bartholomew, A. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur. J. Immunol., 2008, 38(6), 1745-1755.
67. Prasanna, S. J., Gopalakrishnan, D., Shankar, S. R., Vasandan, AB. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One, 2010, 5(2), e9016.
68. Ryan, J. M., Barry, F., Murphy, J. M., Mahon, B. P. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol., 2007, 149(2), 353-363.
69. Valencic, E., Piscianz, E., Andolina, M., Ventura, A., Tommasini, A. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation. Cytotherapy, 2010, 12(2), 154-160.
70. Fang, B., Shi, M., Liao, L., Yang, S., Liu, Y., Zhao, R. C. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation, 2004, 78(1), 83-88.
71. Ninichuk, V., Gross, O., Segerer, S., Hoffmann, R., Radomska, E., Buchstaller, A, Huss, R., Akis, N., Schlondorff, D., Anders, H. J. Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice. Kidney Int., 2006, 70(1), 121-129.
72. Neuss, S., Becher, E., Woltje, M., Tietze, L., Jahnen-Dechent, W. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. Stem Cells, 2004, 22(3), 405-414.
73. Lee, C. H., Shah, B., Moioli, E. K., Mao, J. J. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J. Clin. Invest., 2010, 120(9), 3340-3349.
74. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., Dini, G., Egeler, R. M., Bacigalupo, A., Fibbe, W., Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease, a phase II study. Lancet, 2008, 371(9624), 1579-1586.
75. Bass, A. S., Cartwright, M. E., Mahon, C., Morrison, R., Snyder, R., McNamara, P., Bradley, P., Zhou, Y. Y., Hunter, J. Exploratory drug safety, a discovery strategy to reduce attrition in development. J Pharmacol. Toxicol. Methods, 2009, 60(1), 69-78.
76. McNeish, J. Embryonic stem cells in drug discovery. Nat. Rev. Drug Discov., 2004, 3(1), 70-80.
77. Webb, S. iPS cell technology gains momentum in drug discovery. Nat. Rev. Drug Discov., 2009, 8(4), 263-264.
78. Winkler, J., Sotiriadou, I., Chen, S,. Hescheler, J., Sachinidis, A. The potential of embryonic stem cells combined with-omics technologies as model systems for toxicology. Curr. Med. Chem., 2009, 16(36), 4814-4827.
79. Ding, S., Schultz, P. G. A role for chemistry in stem cell biology. Nat. Biotechnol., 2004, 22(7), 833-840.
80. Ding, S., Schultz, P. G. Small molecules and future regenerative medicine. Curr. Top. Med. Chem., 2005, 5(4), 383-395.
81. Kim, N. R., Kang, S. K., Ahn, H. H., Kwon, S. W., Park, W. S., Kim, K. S., Kim, S. S., Jung, H. J., Choi, S. U., Ahn, J. H., Kim, K. R. Discovery of a new and efficient small molecule for neuronal differentiation from mesenchymal stem cell. J. Med. Chem., 2009, 52(24), 7931-7933.
82. Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., Kazantsev, A. Study of 1, 4-dihydropyridine structural scaffold, discovery of novel sirtuin activators and inhibitors. J. Med. Chem., 2009, 52(17), 5496-5504.
83. Sakai, N., Terami, H., Suzuki, S., Haga, M., Nomoto, K., Tsuchida, N., Morohashi, K., Saito, N., Asada, M., Hashimoto, M., Harada, D., Asahara, H., Ishikawa, T., Shimada, F., Sakurada, K. Identification of NR5A1 (SF-1/AD4BP) gene expression modulators by large-scale gain and loss of function studies. J. Endocrinol., 2008, 198(3), 489-497.
84. Flanagan, J. M., Funes, J. M., Henderson, S., Wild, L., Carey, N., Boshoff, C. Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. Mol. Cancer Ther., 2009, 8(1), 249-260.
85. Patel, S. A., Heinrich, A. C., Reddy, B. Y., Srinivas, B., Heidaran, N., Rameshwar, P. Breast cancer biology, the multifaceted roles of mesenchymal stem cells. J. Oncol., 2008, 2008, 425895.
86. Bushway, P. J., Mercola, M. High-throughput screening for modulators of stem cell differentiation. Methods Enzymol. 2006, 414, 300-316.
87. Kavanagh, H., Mahon, B. P. Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy, 2011, 66(4), 523-531.
88. Erfle, H., Neumann, B., Rogers, P., Bulkescher, J., Ellenberg, J., Pepperkok R. Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates. J. Biomol. Screen, 2008, 13(7), 575-580.
89. Neumann, B., Held, M., Liebel, U., Erfle, H., Rogers, P., Pepperkok, R., Ellenberg, J. High-throughput RNAi screening by time-lapse imaging of live human cells. Nat. Methods, 2006, 3(5), 385-390.
90. Walter, T., Held, M., Neumann, B., Heriche, J. K., Conrad, C., Pepperkok, R., Ellenberg, J. Automatic identification and clustering of chromosome phenotypes in a genome wide RNAi screen by time-lapse imaging. J. Struct. Biol., 2010, 170(1), 1-9.
91. Huang, A. H., Motlekar, N. A., Stein, A., Diamond, S. L., Shore, E. M., Mauck, R. L. High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann. Biomed. Eng., 2008, 36(11), 1909-1921.
92. Kawakami, Y., Tsuda, M., Takahashi, S, Taniguchi, N., Esteban, C. R., Zemmyo, M., Furumatsu, T., Lotz, M., Belmonte, J. C., Asahara, H. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc. Natl. Acad. Sci. U. S. A., 2005, 102(7), 2414-2419.
93. Takada, I., Kouzmenko, A. P., Kato, S. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nat. Rev. Rheumatol., 2009, 5(8), 442-447.
94. Takada, I., Kouzmenko, A. P., Kato, S. Molecular switching of osteoblastogenesis versus adipogenesis, implications for targeted therapies. Expert Opin. Ther. Targets, 2009, 13(5), 593-603.
95. Dicker, A., Kaaman, M., van Harmelen, V., Astrom, G., Blanc, K. L., Ryden, M. Differential function of the alpha2A-adrenoceptor and Phosphodiesterase-3B in human adipocytes of different origin. Int. J. Obes. (Lond)., 2005, 29(12), 1413-1421.
96. McNeish, J. D. Stem cells as screening tools in drug discovery. Curr. Opin. Pharmacol., 2007, 7(5), 515-520.
97. Musina, R. A., Bekchanova, E. S., Belyavskii, A. V., Sukhikh, G. T. Differentiation potential of mesenchymal stem cells of different origin. Bull. Exp. Biol. Med., 2006, 141(1), 147-151.
98. Qian, S. W., Li, X., Zhang, Y. Y., Huang, H. Y., Liu, Y., Sun, X., Tang, Q. Q. Characterization of adipocyte differentiation from human mesenchymal stem cells in bone marrow. BMC Dev. Biol., 2010, 10, 47.
99. Erfle, H., Neumann, B., Liebel, U., Rogers, P., Held, M., Walter, T, Ellenberg, J., Pepperkok, R. Reverse transfection on cell arrays for high content screening microscopy. Nat. Protoc., 2007, 2(2), 392-399.
100. Neumann, B., Walter, T., Heriche, J. K., Bulkescher, J., Erfle, H., Conrad, C., Rogers, P., Poser, I., Held, M., Liebel, U., Cetin, C., Sieckmann, F., Pau, G., Kabbe, R., Wunsche, A., Satagopam, V, Schmitz, M. H., Chapuis, C., Gerlich, D. W., Schneider, R., Eils, R., Huber, W., Peters, J. M., Hyman, A. A., Durbin, R., Pepperkok, R., Ellenberg, J. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature, 2010, 464(7289), 721-727.
101. Freeley, M., Bakos, G., Davies, A., Kelleher, D., Long, A., Dunican, D. J. A high-content analysis toolbox permits dissection of diverse signaling pathways for T lymphocyte polarization. J. Biomol. Screen, 2010, 15(5), 541-555.
102. Kozak, K., Bakos, G., Hoff, A., Bennett, E., Dunican, D., Davies, A, Kelleher, D., Long, A., Csucs, G. Workflow-based software environment for large-scale biological experiments. J. Biomol. Screen, 2010, 15(7), 892-899.
103. Verma, N. K., Davies, A. M., Long, A., Kelleher, D., Volkov, Y. STAT3 knockdown by siRNA induces apoptosis in human cutaneous T-cell lymphoma line Hut78 via downregulation of Bcl-xL. Cell Mol Biol. Lett., 2010, 15(2), 342-355.
104. English, K., French, A., Wood, K. J. Mesenchymal stromal cells, facilitators of successful transplantation? Cell Stem Cell., 2010, 7(4), 431-442.
105. Lopez, M. M., Valenzuela, J. E., Alvarez, F. C., Lopez-Alvarez, M. R., Cecilia, G. S., Paricio, P. P. Long-term problems related to immunosuppression. Transpl. Immunol., 2006, 17(1), 31-35.
106. Ding, Y., Bushell, A., Wood, K. J. Mesenchymal stem-cell immunosuppressive capabilities, therapeutic implications in islet transplantation. Transplantation, 2010, 89(3), 270-273.
107. Colvin, R. B., Smith, R. N. Antibody-mediated organ-allograft rejection. Nat. Rev. Immunol., 2005, 5(10), 807-817.
108. Hall, B. M., Dorsch, S., Roser, B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J. Exp. Med., 1978, 148(4), 878-889.
109. LaRosa, D. F., Rahman, A. H., Turka, L. A. The innate immune system in allograft rejection and tolerance. J. Immunol., 2007, 178(12), 7503-7509.
110. Tu, Z., Li, Q., Bu, H., Lin, F. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev., 2010, 19(11), 1803-1809.
111. Schraufstatter, I. U., Discipio, R. G., Zhao, M., Khaldoyanidi, S. K. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J. Immunol., 2009, 182(6), 3827-3836.
112. Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., Medzhitov, R. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol., 2001, 2(10), 947-950.
113. Liotta, F., Angeli, R., Cosmi, L., Fili, L., Manuelli, C., Frosali, F., Mazzinghi, B., Maggi L, Pasini, A, Lisi, V., Santarlasci, V., Consoloni L., Angelotti, M. L., Romagnani, P, Parronchi, P., Krampera, M., Maggi, E., Romagnani, S., Annunziato, F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells, 2008, 26(1), 279-289.
114. Hwa, C. H., Bae, Y. C., Jung, JS. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells, 2006, 24(12), 2744-2752.
115. Lombardo, E., DelaRosa, O., Mancheno-Corvo, P., Menta, R., Ramirez, C., Buscher, D. Toll-like receptor-mediated signaling in human adipose-derived stem cells, implications for immunogenicity and immunosuppressive potential. Tissue Eng. Part A. 2009, 15(7), 1579-1589.
116. Tomchuck, S. L., Zwezdaryk, K. J., Coffelt, S. B., Waterman, R. S., Danka, E. S., Scandurro, A. B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells, 2008, 26(1), 99-107.
117. Wang, Z. J., Zhang, F. M., Wang, L. S., Yao, Y. W., Zhao, Q., Gao, X. Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol. Int., 2009, 33(6), 665-674.
118. Yao, Y., Zhang, F., Wang, L., Zhang, G., Wang, Z, Chen, J., Gao, X. Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. J. Biomed. Sci., 2009, 16, 74.
119. Grau, V., Herbst, B., Steiniger, B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res., 1998, 291(1), 117-126.
120. Wyburn, K. R., Jose, M. D., Wu, H., Atkins, R. C., Chadban, S. J. The role of macrophages in allograft rejection. Transplantation, 2005, 80(12), 1641-1647.
121. Kim, J., Hematti, P. Mesenchymal stem cell-educated macrophages, a novel type of alternatively activated macrophages. Exp. Hematol., 2009, 37(12), 1445-1453.
122. Nemeth, K., Leelahavanichkul, A., Yuen, P. S., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., Hu, X., Jelinek, I., Star, R. A., Mezey, E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med., 2009, 15(1), 42-49.
123. Mirza, R., DiPietro, L. A., Koh, T. J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol, 2009, 175(6), 2454-2462.
124. Chen, L., Tredget, E. E., Wu, P. Y., Wu, Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One, 2008, 3(4), e1886.
125. Taylor, M. A., Ward, B., Schatzle, J. D., Bennett, M. Perforin-and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur. J. Immunol., 2002, 32(3), 793-799.
126. Aggarwal, S., Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005, 105(4), 1815-1822.
127. Rasmusson, I., Ringden, O., Sundberg, B., Le Blanc, K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003, 76(8), 1208-1213.
128. Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., Moretta, L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production, role of indoleamine 2, 3-dioxygenase and prostaglandin E2. Blood, 2008, 111(3), 1327-1333.
129. Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., Papamichail, M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 2006, 24(1), 74-85.
130. Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C., Moretta, L. Mesenchymal stem cell-natural killer cell interactions, evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 2006, 107(4), 1484-1490.
131. Shoskes, D. A., Wood, K. J. Indirect presentation of MHC antigens in transplantation. Immunol. Today, 1994, 15(1), 32-38.
132. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan H., Galun, E., Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 2005, 105(5), 2214-2219.
133. Djouad, F., Charbonnier, L. M., Bouffi, C., Louis-Plence, P., Bony, C., Apparailly, F., Cantos, C., Jorgensen, C., Noel, D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells, 2007, 25(8), 2025-2032.
134. Jiang, X. X., Zhang, Y., Liu, B., Zhang, S. X., Wu, Y., Yu, X. D., Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, 2005, 105(10), 4120-4126.
135. Nauta, A. J., Kruisselbrink, A. B., Lurvink, E., Willemze, R., Fibbe, W. E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol, 2006, 177(4), 2080-2087.
136. Chen, L., Zhang, W, Yue, H., Han, Q., Chen, B., Shi. M., Li, J., Li, B., You. S., Shi, Y., Zhao, R. C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34+ cells. Stem Cells Dev., 2007, 16(5), 719-731.
137. Li, Y. P., Paczesny, S., Lauret, E., Poirault, S., Bordigoni, P., Mekhloufi F., Hequet, O., Bertrand, Y., Ou-Yang, J. P., Stoltz, J. F., Miossec P, Eljaafari, A. Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol, 2008, 180(3), 1598-1608.
138. Wehner, R., Wehrum, D., Bornhauser, M., Zhao, S., Schakel, K., Bachmann, M. P., Platzbecker, U., Ehninger, G., Rieber, E. P., Schmitz, M. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica, 2009, 94(8), 1151-1156.
139. Zhang, B., Liu, R., Shi, D., Liu, X., Chen, Y., Dou, X., Zhu, X., Lu, C., Liang, W., Liao, L., Zenke, M., Zhao, R. C. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood, 2009, 113(1), 46-57.
140. Zhang, W., Ge, W., Li, C., You, S., Liao, L., Han, Q., Deng, W., Zhao, R. C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev., 2004, 13(3), 263-271.
141. Ge, W., Jiang, J., Baroja, M. L., Arp, J., Zassoko, R., Liu, W., Bartholomew, A., Garcia, B., Wang, H. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am. J. Transplant, 2009, 9(8), 1760-1772.
142. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99(10), 3838-3843.
143. Ding, Y., Xu, D., Feng, G., Bushell, A., Muschel, R. J., Wood, K. J. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and-9. Diabetes, 2009, 58(8), 1797-1806.
144. Karlsson H, Samarasinghe S, Ball LM, Sundberg B, Lankester AC, Dazzi, F., Uzunel, M., Rao, K., Veys, P., Le Blanc, K., Ringden, O, Amrolia, P. J. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood, 2008, 112(3), 532-541.
145. Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., Shi, Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2008, 2(2), 141-150.
146. Ghannam, S., Pene, J., Torcy-Moquet, G., Jorgensen, C., Yssel, H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J. Immunol., 2010, 185(1), 302-312.
147. Rafei, M., Campeau, P. M., Aguilar-Mahecha, A., Buchanan, M., Williams, P., Birman, E., Yuan, S., Young, Y. K., Boivin, M. N, Forner, K., Basik, M., Galipeau, J. Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. J. Immunol., 2009, 182(10), 5994-6002.
148. Casiraghi, F., Azzollini, N., Cassis, P., Imberti, B., Morigi, M., Cugini, D., Cavinato, R. A,. Todeschini, M., Solini, S., Sonzogni, A., Perico, N., Remuzzi, G., Noris, M. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J. Immunol, 2008, 181(6), 3933-3946.
149. Kong, Q. F., Sun, B., Bai, S. S., Zhai, D. X., Wang, G. Y., Liu, Y. M., Zhang SJ, Li, R., Zhao, W., Sun, Y. Y., Li, N., Wang, Q., Peng, H. S., Jin, L. H., Li, H. L. Administration of bone marrow stromal cells ameliorates experimental autoimmune myasthenia gravis by altering the balance of Th1/Th2/Th17/Treg cell subsets through the secretion of TGF-beta. J. Neuroimmunol., 2009, 207(1-2), 83-91.
150. Long, E., Wood, K. J. Regulatory T cells in transplantation, transferring mouse studies to the clinic. Transplantation, 2009, 88(9), 1050-1056.
151. Nadig, S. N., Wieckiewicz, J., Wu, D. C., Warnecke, G., Zhang, W., Luo, S., Schiopu, A., Taggart, D. P., Wood, K. J. In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat. Med., 2010, 16(7), 809-813.
152. Wood, K. J., Sakaguchi, S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol., 2003, 3(3), 199-210.
153. English, K., Ryan, J. M., Tobin, L., Murphy, M. J., Barry F. P., Mahon, B. P. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin. Exp. Immunol., 2009, 156(1), 149-160.
154. Nasef A, Mazurier C, Bouchet S, Francois S, Chapel A, Thierry D, Gorin NC, Fouillard L. Leukemia inhibitory factor, Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol. 2008, 253(1-2), 16-22.
155. Selmani, Z, Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E. D., Deschaseaux, F. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells, 2008, 26(1), 212-222.
156. Maccario, R., Podesta, M., Moretta, A., Cometa, A., Comoli, P., Montagna, D., Daudt, L., Ibatici, A., Piaggio G, Pozzi, S., Frassoni, F, Locatelli, F. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005, 90(4), 516-525.
157. Ramasamy, R., Tong, C. K., Seow, H. F., Vidyadaran, S,. Dazzi, F. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function. Cell Immunol., 2008, 251(2), 131-136.
158. Asari, S., Itakura, S., Ferreri, K., Liu, C. P., Kuroda, Y., Kandeel, F., Mullen, Y. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp. Hematol., 2009, 37(5), 604-615.
159. Comoli, P., Ginevri, F., Maccario, R., Avanzini, M. A., Marconi, M., Groff, A., Cometa, A., Cioni, M., Porretti, L., Barberi, W., Frassoni, F., Locatelli F. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol. Dial. Transplant., 2008, 23(4), 1196-1202.
160. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi F, Mancardi, G. L., Pistoia, V., Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006, 107(1), 367-372.
161. Gerdoni, E., Gallo, B., Casazza, S., Musio, S., Bonanni, I, Pedemonte, E., Mantegazza R, Frassoni F, Mancardi, G., Pedotti, R., Uccelli, A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol., 2007, 61(3), 219-227.
162. Rafei, M., Hsieh, J., Fortier, S., Li, M., Yuan, S., Birman, E., Forner, K., Boivin, M. N., Doody, K., Tremblay, M., Annabi, B., Galipeau, J. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood, 2008, 112(13), 4991-4998.
163. Schena F, Gambini C, Gregorio A, Mosconi, M., Reverberi, D., Gattorno, M., Casazza, S., Uccelli, A., Moretta, L., Martini, A., Traggiai, E. Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum., 2010, 62(9), 2776-2786.
164. Tabera, S., Perez-Simon, J. A., Diez-Campelo, M., Sanchez-Abarca, L. I., Blanco, B., Lopez, A., Benito, A., Ocio, E., Sanchez-Guijo, F. M., Canizo, C., San, M. J. F. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica, 2008, 93(9), 1301-1309.
165. Youd, M., Blickarz, C., Woodworth, L., Touzjian, T., Edling, A., Tedstone, J., Ruzek, M., Tubo, R., Kaplan, J., Lodie, T. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol., 2010, 161(1), 176-186.
166. Koc, O. N., Gerson, S. L., Cooper, B. W., Dyhouse, S. M., Haynesworth, S. E., Caplan, A. I., Lazarus, H. M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol., 2000, 18(2), 307-316.
167. Lazarus, H. M., Koc, O. N., Devine, S. M., Curtin, P., Maziarz, R. T., Holland H. K., Shpall, E. J., McCarthy, P., Atkinson, K., Cooper, B. W., Gerson, S. L., Laughlin, M. J., Loberiza, F. R., Jr., Moseley, A. B., Bacigalupo, A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant., 2005, 11(5), 389-398.